| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.VPH.2006.11.002 |
| P698 | PubMed publication ID | 17178255 |
| P2093 | author name string | Utako Kaneyuki | |
| Masamichi Kojiro | |||
| Seiya Kato | |||
| Seiya Okuda | |||
| Sho-ichi Yamagishi | |||
| Seiji Ueda | |||
| Koichi Oshima | |||
| Junko Yoshimura | |||
| Ayako Hayashida | |||
| Ryo Shibata | |||
| Toshiko Fujimura | |||
| P2860 | cites work | Oxygen free radical release in human failing myocardium is associated with increased activity of rac1-GTPase and represents a target for statin treatment | Q42447271 |
| Phenotypic modulation of vascular smooth muscle cells induced by unsaturated lysophosphatidic acids | Q43696097 | ||
| Pigment epithelium-derived factor prevents advanced glycation end products-induced monocyte chemoattractant protein-1 production in microvascular endothelial cells by suppressing intracellular reactive oxygen species generation | Q44355887 | ||
| Calcitonin receptor isoforms expressed in the developing rat kidney | Q44358508 | ||
| Subtype-selective antagonists of lysophosphatidic Acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaques | Q44529184 | ||
| Plaque rupture, lysophosphatidic acid, and thrombosis | Q44545464 | ||
| Regulation of mitogen-activated protein kinase cascades by low density lipoprotein and lysophosphatidic acid | Q44859407 | ||
| Inhibitory efficacy of pitavastatin on the early inflammatory response and neointimal thickening in a porcine coronary after stenting | Q44890789 | ||
| Pigment epithelium-derived factor inhibits TNF-alpha-induced interleukin-6 expression in endothelial cells by suppressing NADPH oxidase-mediated reactive oxygen species generation. | Q44994254 | ||
| AGEs activate mesangial TGF-beta-Smad signaling via an angiotensin II type I receptor interaction | Q45166188 | ||
| Pigment epithelium-derived factor (PEDF) blocks angiotensin II signaling in endothelial cells via suppression of NADPH oxidase: a novel anti-oxidative mechanism of PEDF. | Q46450720 | ||
| Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis | Q46897070 | ||
| Convergence of redox-sensitive and mitogen-activated protein kinase signaling pathways in tumor necrosis factor-alpha-mediated monocyte chemoattractant protein-1 induction in vascular smooth muscle cells | Q73435144 | ||
| Platelet-derived growth factor-stimulated superoxide anion production modulates activation of transcription factor NF-kappaB and expression of monocyte chemoattractant protein 1 in human aortic smooth muscle cells | Q73804432 | ||
| Coordinate regulation of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 expression in human vascular smooth muscle cells | Q74327226 | ||
| Stimulation of a vascular smooth muscle cell NAD(P)H oxidase by thrombin. Evidence that p47(phox) may participate in forming this oxidase in vitro and in vivo | Q77955201 | ||
| Atherosclerosis — An Inflammatory Disease | Q26776972 | ||
| Vascular smooth muscle migration and proliferation in response to lysophosphatidic acid (LPA) is mediated by LPA receptors coupling to Gq | Q28566091 | ||
| Lysophosphatidic acid synthesis and release | Q28609420 | ||
| Characterization of rac and cdc42 activation in chemoattractant-stimulated human neutrophils using a novel assay for active GTPases | Q29618793 | ||
| Cellular antioxidant effects of atorvastatin in vitro and in vivo | Q30809431 | ||
| Cellular adhesion molecules on vascular smooth muscle cells | Q33643470 | ||
| Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability | Q34023805 | ||
| Monocyte chemoattractant protein-1 in human atheromatous plaques | Q34203056 | ||
| Athero- and thrombogenic actions of lysophosphatidic acid and sphingosine-1-phosphate | Q34691540 | ||
| Lysophospholipids and the cardiovascular system | Q34691544 | ||
| Current molecular models for NADPH oxidase regulation by Rac GTPase | Q34915029 | ||
| Role of oxidative stress in atherosclerosis | Q35088521 | ||
| Minodronate, a newly developed nitrogen-containing bisphosphonate, suppresses melanoma growth and improves survival in nude mice by blocking vascular endothelial growth factor signaling | Q35103539 | ||
| Rac regulates cardiovascular superoxide through diverse molecular interactions: more than a binary GTP switch | Q35212986 | ||
| Reactive oxygen species in the vasculature: molecular and cellular mechanisms | Q35569201 | ||
| Vascular NADPH oxidases: molecular mechanisms of activation. | Q35994483 | ||
| Lysophospholipids increase ICAM-1 expression in HUVEC through a Gi- and NF-kappaB-dependent mechanism | Q40528453 | ||
| NK-104, a newly developed HMG-CoA reductase inhibitor, suppresses neointimal thickening by inhibiting smooth muscle cell growth and fibronectin production in balloon-injured rabbit carotid artery | Q41021554 | ||
| Lysophosphatidic acid and intracellular signalling in vascular smooth muscle cells | Q42437572 | ||
| P433 | issue | 4 | |
| P921 | main subject | reactive oxygen species | Q424361 |
| P1104 | number of pages | 7 | |
| P304 | page(s) | 286-292 | |
| P577 | publication date | 2006-11-14 | |
| P1433 | published in | Vascular Pharmacology | Q7916446 |
| P1476 | title | Pitavastatin inhibits lysophosphatidic acid-induced proliferation and monocyte chemoattractant protein-1 expression in aortic smooth muscle cells by suppressing Rac-1-mediated reactive oxygen species generation. | |
| P478 | volume | 46 |
| Q42119338 | Antithrombotic actions of statins involve PECAM-1 signaling |
| Q38313076 | Could changes in adiponectin drive the effect of statins on the risk of new-onset diabetes? The case of pitavastatin. |
| Q44628998 | Counter-regulation by atorvastatin of gene modulations induced by L-NAME hypertension is associated with vascular protection |
| Q40311279 | Effects of pitavastatin and pravastatin on markers of immune activation and arterial inflammation in HIV. |
| Q33781318 | Endosomal H2O2 production leads to localized cysteine sulfenic acid formation on proteins during lysophosphatidic acid-mediated cell signaling |
| Q33727578 | LPA induces IL-6 secretion from aortic smooth muscle cells via an LPA1-regulated, PKC-dependent, and p38alpha-mediated pathway |
| Q42414579 | Lipid phosphate phosphatase 3 negatively regulates smooth muscle cell phenotypic modulation to limit intimal hyperplasia |
| Q28475561 | Literature mining for the discovery of hidden connections between drugs, genes and diseases |
| Q46335434 | LysoPtdOH enhances CXCL16 production stimulated by LPS from macrophages and regulates T cell migration |
| Q35907288 | Lysophosphatidic acid causes endothelial dysfunction in porcine coronary arteries and human coronary artery endothelial cells |
| Q39608397 | Lysophosphatidic acid effects on atherosclerosis and thrombosis |
| Q34273486 | Lysophosphatidic acid in atherosclerotic diseases |
| Q36080532 | Lysophosphatidic acid induces early growth response-1 (Egr-1) protein expression via protein kinase Cδ-regulated extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) activation in vascular smooth muscle cells |
| Q34433358 | Lysophosphatidic acid induces integrin activation in vascular smooth muscle and alters arteriolar myogenic vasoconstriction |
| Q37384489 | Lysophosphatidic acid-induced arterial wall remodeling: requirement of PPARgamma but not LPA1 or LPA2 GPCR. |
| Q92083288 | Pitavastatin Exerts Potent Anti-Inflammatory and Immunomodulatory Effects via the Suppression of AP-1 Signal Transduction in Human T Cells |
| Q37776512 | Pitavastatin for the treatment of primary hyperlipidemia and mixed dyslipidemia |
| Q43919904 | Plasticity-related gene-1 inhibits lysophosphatidic acid-induced vascular smooth muscle cell migration and proliferation and prevents neointima formation |
| Q34633506 | Pleiotropic effects of pitavastatin |
| Q46452564 | Pleiotropic effects of statins may improve outcomes in atherosclerotic renovascular disease |
| Q33713850 | Reactive oxygen species mediate lysophosphatidic acid induced signaling in ovarian cancer cells. |
| Q35660165 | Role of taurine in the vasculature: an overview of experimental and human studies |
| Q38498393 | Smooth muscle cell arachidonic acid release, migration, and proliferation are markedly attenuated in mice null for calcium-independent phospholipase A2beta |
| Q36975163 | Smooth muscle hyperplasia due to loss of smooth muscle α-actin is driven by activation of focal adhesion kinase, altered p53 localization and increased levels of platelet-derived growth factor receptor-β. |
| Q36816542 | Suppression of the Rho/Rho-kinase pathway and prevention of cerebral vasospasm by combination treatment with statin and fasudil after subarachnoid hemorrhage in rabbit. |
| Q38018554 | The NADPH oxidase family and its inhibitors. |
| Q42055454 | The phospholipase A2 activity of peroxiredoxin 6 modulates NADPH oxidase 2 activation via lysophosphatidic acid receptor signaling in the pulmonary endothelium and alveolar macrophages. |
| Q36981302 | The potential health benefits of taurine in cardiovascular disease |
| Q92983450 | Therapeutic role of taurine as antioxidant in reducing hypertension risks in rats |
Search more.